植物雌激素改善结肠炎的研究进展
The Research Progress of Phytoestrogens in Improving Colitis
DOI: 10.12677/pi.2025.144031, PDF,   
作者: 赵绵江, 戴 岳*:中国药科大学中药学院中药药理学与中医药学系,江苏 南京
关键词: 植物雌激素炎症免疫肠道屏障肠道菌群 Phytoestrogens Inflammation Immunity Gut Barrier Gut Microbiota
摘要: 溃疡性结肠炎(Ulcerative Colitis, UC)是一种反复发作的慢性炎症性肠病,性别差异在UC的流行病学、症状表现以及治疗反应中起着重要作用。女性的激素水平波动,特别是妊娠期和月经周期等生理变化,在一定程度上改善该疾病的活动性。男性与女性的UC发病率无明显差异,但男性的疾病活动性和严重程度更高。植物雌激素是具有雌激素特性的小分子化合物,与人体雌激素受体亲和力高,在治疗乳腺癌、骨质疏松症、动脉粥样硬化、神经退行性疾病和自身免疫性疾病等疾病呈现良好的前景。植物雌激素具有抗结肠炎的效应,在抑制炎症反应、调节免疫应答、保护肠道屏障和维持肠道菌群健康等方面发挥重要作用。本文主要阐述植物雌激素的作用与机制,以及从炎症、免疫、肠道屏障和菌群的角度对植物雌激素改善实验性结肠炎的作用机制进行归纳总结,为该领域的研究提供参考。
Abstract: Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease, and gender differences play a significant role in the epidemiology, clinical manifestation, and therapeutic response of UC. Fluctuations in estrogen levels in females, particularly during pregnancy and the menstrual cycle, can partially improve the disease activity. The incidence of UC is similar between males and females; however, males tend to have more severe disease activity and greater severity. Phytoestrogens are small molecules with estrogen-like properties that exhibit a high affinity for human estrogen receptors. They show promising potential in the treatment of various diseases, such as breast cancer, osteoporosis, atherosclerosis, neurodegenerative diseases, and autoimmune diseases. Phytoestrogens have demonstrated anti-colitis effects, playing an important role in inhibiting inflammatory responses, regulating immune responses, protecting the intestinal barrier, and maintaining gut microbiota health. This paper primarily discusses the actions and mechanisms of phytoestrogens, summarizing their mechanisms in improving experimental colitis from the perspectives of inflammation, immunity, intestinal barrier, and microbiota, thus providing a reference for further research in this field.
文章引用:赵绵江, 戴岳. 植物雌激素改善结肠炎的研究进展[J]. 药物资讯, 2025, 14(4): 269-276. https://doi.org/10.12677/pi.2025.144031

参考文献

[1] Bruner, L.P., White, A.M. and Proksell, S. (2023) Inflammatory Bowel Disease. Primary Care: Clinics in Office Practice, 50, 411-427. [Google Scholar] [CrossRef] [PubMed]
[2] Kaplan, G.G. (2015) The Global Burden of IBD: From 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12, 720-727. [Google Scholar] [CrossRef] [PubMed]
[3] Kobayashi, T., Siegmund, B., Le Berre, C., Wei, S.C., Ferrante, M., Shen, B., et al. (2020) Ulcerative Colitis. Nature Reviews Disease Primers, 6, Article No. 74. [Google Scholar] [CrossRef] [PubMed]
[4] Singh, N. and Bernstein, C.N. (2022) Environmental Risk Factors for Inflammatory Bowel Disease. United European Gastroenterology Journal, 10, 1047-1053. [Google Scholar] [CrossRef] [PubMed]
[5] Du, L. and Ha, C. (2020) Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterology Clinics of North America, 49, 643-654. [Google Scholar] [CrossRef] [PubMed]
[6] Guo, M. and Wang, X. (2023) Pathological Mechanism and Targeted Drugs of Ulcerative Colitis: A Review. Medicine, 102, e35020. [Google Scholar] [CrossRef] [PubMed]
[7] Liang, Y., Li, Y., Lee, C., Yu, Z., Chen, C. and Liang, C. (2024) Ulcerative Colitis: Molecular Insights and Intervention Therapy. Molecular Biomedicine, 5, Article No. 42. [Google Scholar] [CrossRef] [PubMed]
[8] Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., et al. (2022) Psychological Stress in Inflammatory Bowel Disease: Psychoneuroimmunological Insights into Bidirectional Gut-Brain Communications. Frontiers in Immunology, 13, Article ID: 1016578. [Google Scholar] [CrossRef] [PubMed]
[9] Lungaro, L., Costanzini, A., Manza, F., Barbalinardo, M., Gentili, D., Guarino, M., et al. (2023) Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review. Journal of Personalized Medicine, 13, Article No. 165. [Google Scholar] [CrossRef] [PubMed]
[10] Rustgi, S.D., Kayal, M. and Shah, S.C. (2020) Sex-Based Differences in Inflammatory Bowel Diseases: A Review. Therapeutic Advances in Gastroenterology, 13, 1-11. [Google Scholar] [CrossRef] [PubMed]
[11] Chavda, V.P., Chaudhari, A.Z., Balar, P.C., Gholap, A. and Vora, L.K. (2024) Phytoestrogens: Chemistry, Potential Health Benefits, and Their Medicinal Importance. Phytotherapy Research, 38, 3060-3079. [Google Scholar] [CrossRef] [PubMed]
[12] Sirotkin, A.V. and Harrath, A.H. (2014) Phytoestrogens and Their Effects. European Journal of Pharmacology, 741, 230-236. [Google Scholar] [CrossRef] [PubMed]
[13] Canivenc-Lavier, M. and Bennetau-Pelissero, C. (2023) Phytoestrogens and Health Effects. Nutrients, 15, Article No. 317. [Google Scholar] [CrossRef] [PubMed]
[14] Dixon, R.A. (2004) Phytoestrogens. Annual Review of Plant Biology, 55, 225-261. [Google Scholar] [CrossRef] [PubMed]
[15] Patra, S., Gorai, S., Pal, S., Ghosh, K., Pradhan, S. and Chakrabarti, S. (2023) A Review on Phytoestrogens: Current Status and Future Direction. Phytotherapy Research, 37, 3097-3120. [Google Scholar] [CrossRef] [PubMed]
[16] Domínguez-López, I., Yago-Aragón, M., Salas-Huetos, A., Tresserra-Rimbau, A. and Hurtado-Barroso, S. (2020) Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review. Nutrients, 12, Article No. 2456. [Google Scholar] [CrossRef] [PubMed]
[17] Garcia-Villatoro, E.L. and Allred, C.D. (2021) Estrogen Receptor Actions in Colitis. Essays in Biochemistry, 65, 1003-1013. [Google Scholar] [CrossRef] [PubMed]
[18] Arao, Y. and Korach, K.S. (2021) The Physiological Role of Estrogen Receptor Functional Domains. Essays in Biochemistry, 65, 867-875. [Google Scholar] [CrossRef] [PubMed]
[19] Jia, M., Dahlman-Wright, K. and Gustafsson, J. (2015) Estrogen Receptor Alpha and Beta in Health and Disease. Best Practice & Research Clinical Endocrinology & Metabolism, 29, 557-568. [Google Scholar] [CrossRef] [PubMed]
[20] Arterburn, J.B. and Prossnitz, E.R. (2023) G Protein-Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications. Annual Review of Pharmacology and Toxicology, 63, 295-320. [Google Scholar] [CrossRef] [PubMed]
[21] Prossnitz, E.R. and Barton, M. (2011) The G-Protein-Coupled Estrogen Receptor GPER in Health and Disease. Nature Reviews Endocrinology, 7, 715-726. [Google Scholar] [CrossRef] [PubMed]
[22] Kiyama, R. (2017) Estrogenic Potentials of Traditional Chinese Medicine. The American Journal of Chinese Medicine, 45, 1365-1399. [Google Scholar] [CrossRef] [PubMed]
[23] Wang, T., Huang, Y., Jiang, P., Yuan, X., Long, Q., Yan, X., et al. (2025) Research Progress on Anti-Inflammatory Drugs for Preventing Colitis-Associated Colorectal Cancer. International Immunopharmacology, 144, Article ID: 113583. [Google Scholar] [CrossRef] [PubMed]
[24] Honap, S., Jairath, V., Sands, B.E., Dulai, P.S., Danese, S. and Peyrin-Biroulet, L. (2024) Acute Severe Ulcerative Colitis Trials: The Past, the Present and the Future. Gut, 73, 1763-1773. [Google Scholar] [CrossRef] [PubMed]
[25] Deng, M., Chen, H., Long, J., Song, J., Xie, L. and Li, X. (2020) Calycosin: A Review of Its Pharmacological Effects and Application Prospects. Expert Review of Anti-infective Therapy, 19, 911-925. [Google Scholar] [CrossRef] [PubMed]
[26] Chao, L., Zheng, P., Xia, L., et al. (2017) Calycosin Attenuates Dextran Sulfate Sodium-Induced Experimental Colitis. Iranian Journal of Basic Medical Sciences, 20, 1056-1062.
[27] Yu, L., Rios, E., Castro, L., Liu, J., Yan, Y. and Dixon, D. (2021) Genistein: Dual Role in Women’s Health. Nutrients, 13, Article No. 3048. [Google Scholar] [CrossRef] [PubMed]
[28] Fan, W., Zhang, S., Wu, Y., Lu, T., Liu, J., Cao, X., et al. (2021) Genistein-Derived Ros-Responsive Nanoparticles Relieve Colitis by Regulating Mucosal Homeostasis. ACS Applied Materials & Interfaces, 13, 40249-40266. [Google Scholar] [CrossRef] [PubMed]
[29] Liu, J., Viswanadhapalli, S., Garcia, L., Zhou, M., Nair, B.C., Kost, E., et al. (2017) Therapeutic Utility of Natural Estrogen Receptor Beta Agonists on Ovarian Cancer. Oncotarget, 8, 50002-50014. [Google Scholar] [CrossRef] [PubMed]
[30] Min, J.K., Lee, C.H., Jang, S., Park, J., Lim, S., Kim, D., et al. (2015) Amelioration of Trinitrobenzene Sulfonic Acid‐induced Colitis in Mice by Liquiritigenin. Journal of Gastroenterology and Hepatology, 30, 858-865. [Google Scholar] [CrossRef] [PubMed]
[31] Zhao, Q., Feng, J., Liu, F., Liang, Q., Xie, M., Dong, J., et al. (2024) Rhizoma Drynariae-Derived Nanovesicles Reverse Osteoporosis by Potentiating Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells via Targeting Erα Signaling. Acta Pharmaceutica Sinica B, 14, 2210-2227. [Google Scholar] [CrossRef] [PubMed]
[32] Cao, H., Liu, J., Shen, P., Cai, J., Han, Y., Zhu, K., et al. (2018) Protective Effect of Naringin on DSS-Induced Ulcerative Colitis in Mice. Journal of Agricultural and Food Chemistry, 66, 13133-13140. [Google Scholar] [CrossRef] [PubMed]
[33] Lee, K., Kim, M., Yuk, H.J., Jo, Y., Kim, H.J., Kim, J., et al. (2024) Alleviating Depressive-Like Behavior in DSS-Induced Colitis Mice: Exploring Naringin and Poncirin from Poncirus Trifoliata Extracts. Biomedicine & Pharmacotherapy, 175, Article ID: 116770. [Google Scholar] [CrossRef] [PubMed]
[34] Zhang, Y., Pan, H., Yu, C., Liu, R., Xing, B., Jia, B., et al. (2023) Phytoestrogen-Derived Multifunctional Ligands for Targeted Therapy of Breast Cancer. Asian Journal of Pharmaceutical Sciences, 18, Article ID: 100827. [Google Scholar] [CrossRef] [PubMed]
[35] Hu, C., Chen, Y., Jin, T., Wang, Z., Jin, B., Liao, J., et al. (2024) A Derivative of Tanshinone IIA and Salviadione, 15a, Inhibits Inflammation and Alleviates DSS-Induced Colitis in Mice by Direct Binding and Inhibition of RIPK2. Acta Pharmacologica Sinica, 46, 672-686. [Google Scholar] [CrossRef] [PubMed]
[36] Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., Sánchez-Martinez, H. and Gonzalez-Granado, J.M. (2023) Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. International Journal of Molecular Sciences, 24, Article No. 1526. [Google Scholar] [CrossRef] [PubMed]
[37] Giesler, S., Riemer, R., Lowinus, T. and Zeiser, R. (2025) Immune-Mediated Colitis after Immune Checkpoint Inhibitor Therapy. Trends in Molecular Medicine, 31, 265-280. [Google Scholar] [CrossRef] [PubMed]
[38] Liao, D., Liu, Y., Li, C., He, B., Zhou, G., Cui, Y., et al. (2023) Arctigenin Hinders the Invasion and Metastasis of Cervical Cancer Cells via the Fak/paxillin Pathway. Heliyon, 9, e16683. [Google Scholar] [CrossRef] [PubMed]
[39] Wu, X., Dou, Y., Yang, Y., Bian, D., Luo, J., Tong, B., et al. (2015) Arctigenin Exerts Anti-Colitis Efficacy through Inhibiting the Differentiation of Th1 and Th17 Cells via an Mtorc1-Dependent Pathway. Biochemical Pharmacology, 96, 323-336. [Google Scholar] [CrossRef] [PubMed]
[40] Khushboo, M., Sanjeev, S., Murthy, M.K., Sunitadevi, M., Dinata, R., Bhanushree, B., et al. (2023) Dietary Phytoestrogen Diosgenin Interrupts Metabolism, Physiology, and Reproduction of Swiss Albino Mice: Possible Mode of Action as an Emerging Environmental Contaminant, Endocrine Disruptor and Reproductive Toxicant. Food and Chemical Toxicology, 176, Article ID: 113798. [Google Scholar] [CrossRef] [PubMed]
[41] Wu, M., Wang, Q., Huang, B., Mai, C., Wang, C., Wang, T., et al. (2021) Dioscin Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization. Pharmacological Research, 172, Article ID: 105796. [Google Scholar] [CrossRef] [PubMed]
[42] Wong, K., Kong, T., Poon, C.C., Yu, W., Zhou, L. and Wong, M. (2023) Icariin, a Phytoestrogen, Exerts Rapid Estrogenic Actions through Crosstalk of Estrogen Receptors in Osteoblasts. Phytotherapy Research, 37, 4706-4721. [Google Scholar] [CrossRef] [PubMed]
[43] Tao, F., Qian, C., Guo, W., Luo, Q., Xu, Q. and Sun, Y. (2013) Inhibition of Th1/Th17 Responses via Suppression of STAT1 and STAT3 Activation Contributes to the Amelioration of Murine Experimental Colitis by a Natural Flavonoid Glucoside Icariin. Biochemical Pharmacology, 85, 798-807. [Google Scholar] [CrossRef] [PubMed]
[44] Lee, D., Kim, Y., Chin, Y. and Kang, K.S. (2021) Schisandrol a Exhibits Estrogenic Activity via Estrogen Receptor Α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells. Pharmaceutics, 13, Article No. 1082. [Google Scholar] [CrossRef] [PubMed]
[45] Ma, Z., Xu, G., Shen, Y., Hu, S., Lin, X., Zhou, J., et al. (2021) Schisandrin B-Mediated Th17 Cell Differentiation Attenuates Bowel Inflammation. Pharmacological Research, 166, Article ID: 105459. [Google Scholar] [CrossRef] [PubMed]
[46] Iacucci, M., Santacroce, G., Majumder, S., Morael, J., Zammarchi, I., Maeda, Y., et al. (2024) Opening the Doors of Precision Medicine: Novel Tools to Assess Intestinal Barrier in Inflammatory Bowel Disease and Colitis-Associated Neoplasia. Gut, 73, 1749-1762. [Google Scholar] [CrossRef] [PubMed]
[47] Qiao, Y., He, C., Xia, Y., Ocansey, D.K.W. and Mao, F. (2025) Intestinal Mucus Barrier: A Potential Therapeutic Target for IBD. Autoimmunity Reviews, 24, Article ID: 103717. [Google Scholar] [CrossRef] [PubMed]
[48] Yang, Y., Chen, D., Li, Y., Zou, J., Han, R., Li, H., et al. (2022) Effect of Puerarin on Osteogenic Differentiation in Vitro and on New Bone Formation in Vivo. Drug Design, Development and Therapy, 16, 2885-2900. [Google Scholar] [CrossRef] [PubMed]
[49] Wu, Y., Li, Y., Ruan, Z., Li, J., Zhang, L., Lu, H., et al. (2020) Puerarin Rebuilding the Mucus Layer and Regulating Mucin-Utilizing Bacteria to Relieve Ulcerative Colitis. Journal of Agricultural and Food Chemistry, 68, 11402-11411. [Google Scholar] [CrossRef] [PubMed]
[50] Novakovic, R., Rajkovic, J., Gostimirovic, M., Gojkovic-Bukarica, L. and Radunovic, N. (2022) Resveratrol and Reproductive Health. Life, 12, Article No. 294. [Google Scholar] [CrossRef] [PubMed]
[51] Pan, H., Zhou, X., Ma, Y., Pan, W., Zhao, F., Yu, M., et al. (2020) Resveratrol Alleviates Intestinal Mucosal Barrier Dysfunction in Dextran Sulfate Sodium-Induced Colitis Mice by Enhancing Autophagy. World Journal of Gastroenterology, 26, 4945-4959. [Google Scholar] [CrossRef] [PubMed]
[52] Wang, X., Peng, J., Cai, P., Xia, Y., Yi, C., Shang, A., et al. (2024) The Emerging Role of the Gut Microbiota and Its Application in Inflammatory Bowel Disease. Biomedicine & Pharmacotherapy, 179, Article ID: 117302. [Google Scholar] [CrossRef] [PubMed]
[53] Bethlehem, L., Estevinho, M.M., Grinspan, A., Magro, F., Faith, J.J. and Colombel, J. (2024) Microbiota Therapeutics for Inflammatory Bowel Disease: The Way Forward. The Lancet Gastroenterology & Hepatology, 9, 476-486. [Google Scholar] [CrossRef] [PubMed]
[54] Oh, S.M., Kim, Y.P. and Chung, K.H. (2006) Biphasic Effects of Kaempferol on the Estrogenicity in Human Breast Cancer Cells. Archives of Pharmacal Research, 29, 354-362. [Google Scholar] [CrossRef] [PubMed]
[55] Qu, Y., Li, X., Xu, F., Zhao, S., Wu, X., Wang, Y., et al. (2021) Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis. Frontiers in Immunology, 12, Article ID: 679897. [Google Scholar] [CrossRef] [PubMed]
[56] Al‐Shami, A.S., Essawy, A.E. and Elkader, H.A.E.A. (2023) Molecular Mechanisms Underlying the Potential Neuroprotective Effects of Trifolium pratense and Its Phytoestrogen‐Isoflavones in Neurodegenerative Disorders. Phytotherapy Research, 37, 2693-2737. [Google Scholar] [CrossRef] [PubMed]
[57] Ceccarelli, I., Bioletti, L., Peparini, S., Solomita, E., Ricci, C., Casini, I., et al. (2022) Estrogens and Phytoestrogens in Body Functions. Neuroscience & Biobehavioral Reviews, 132, 648-663. [Google Scholar] [CrossRef] [PubMed]
[58] Xue, J., Yuan, S., Meng, H., Hou, X., Li, J., Zhang, H., et al. (2023) The Role and Mechanism of Flavonoid Herbal Natural Products in Ulcerative Colitis. Biomedicine & Pharmacotherapy, 158, Article ID: 114086. [Google Scholar] [CrossRef] [PubMed]